Concepedia

Shenxia Xie

SX

Statistics

Publications

6

Citations

206

H-Index

6

Active since

2021

Affiliations

Guangxi Medical University(Current)

Huazhong University of Science and Technology

Union Hospital

Tumor Hospital of Guangxi Medical University

The University of Queensland

Shenxia Xie is an author at Guangxi Medical University specializing in oncology, cancer immunotherapy, and immunology.

Publications per year

2021–2023

6

Publications

6

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

Fengzhen Mo, Siliang Duan, Xiaobing Jiang et al. · Signal Transduction and Targeted Therapy · 2021 · 81 citations · Full text

, , +17

A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine

Wei Shi, Xiaomei Yang, Shenxia Xie et al. · Cancer Letters · 2021 · 39 citations

, , +16

Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression

Ziqiang Ding, Shuyang Sun, Xuan Wang et al. · Journal of Hematology & Oncology · 2023 · 28 citations · Full text

, , +17

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor

Shuyang Sun, Ziqiang Ding, Li Gao et al. · Theranostics · 2023 · 23 citations · Full text

, , +17

Nanobody-based CAR T cells targeting intracellular tumor antigens

Haixia Li, Dani Zhong, Huiguan Luo et al. · Biomedicine & Pharmacotherapy · 2022 · 19 citations · Full text

, , +17

1–5 of 6